Singapore: Shionogi, one of Japan's biggest pharmaceutical companies, has signed a memorandum of understanding (MoU) for an R&D partnership with six Irish universities, under the company's Shionogi Science Programme. For now, the collaboration... Read more
Singapore: Japanese drug major Daiichi Sankyo submitted a New Drug Application to the Ministry of Health, Labor and Welfare... Read more
Singapore: Prism Pharma, a drug discovery company focused on developing small molecule technologies that modulate protein-protein... Read more
Singapore: Orexo entered into an agreement with AstraZeneca regarding preclinical program OX-CLI for a potential novel treatment of respiratory... Read more
Singapore: The US FDA has approved Exjade (deferasirox) for the treatment of chronic iron overload in patients 10 years of age and older... Read more
Singapore: Researchers from A*Star's Institute of Bioengineering and Nanotechnology (IBN) and IBM have unveiled first-ever antimicrobial... Read more
Singapore: Researchers at the Centre for Vision Research from the Westmead Millennium Institute for Medical Research (WMI), a close affiliate... Read more
Singapore: European Commission has approved Novartis' Bexsero (Meningococcal Group B Vaccine [rDNA, component, adsorbed]) for use in individuals... Read more
Singapore: South Korea's Dong-A Pharmaceutical announced positive top-line results from its phase II clinical trial of DPP-4 inhibitor,... Read more
Singapore: Associate Professor Matthias Ernst and colleagues from Australia's Walter and Eliza Hall Institute have identified a complex... Read more
Singapore: France-based biopharma company NovAliX entered into a fragment-based drug discovery alliance with Kyowa Hakko Kirin of Japan.... Read more
Singapore: Patrys, Australia's clinical stage biopharmaceutical company, has received approval to progress its phase I/IIa PAT-SM6 multiple... Read more
Survey Box